封面
市場調查報告書
商品編碼
1588364

生物晶片市場規模、佔有率、趨勢分析報告:按類型、最終用途、按地區、細分市場預測,2025-2030 年

Biochip Market Size, Share & Trends Analysis Report By Type (DNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

生物晶片市場成長與趨勢:

Grand View Research, Inc.最新報告顯示,預計到2030年,全球生物晶片市場規模將達263億美元,2025年至2030年複合年成長率為11.41%。

對藥物發現和開發的需求不斷成長,加上個人化醫療的採用,可能會推動產業成長。此外,世界各地生物技術公司擴大採用次世代定序正在推動產品需求。例如,2021 年 12 月,雅培的 i-STAT TBI 血漿測試獲得了 CE 標誌,這是一種可攜式創傷性腦損傷 (TBI) 血液分析儀。因此,該公司被允許擴大在歐盟(EU)的業務。定序技術的創新使研究人員能夠將 DNA 分子解碼至完整人類基因組的層次。

Thermo Fisher Scientific 的 Ion Torrent 晶片是一種基於合成序列的技術。該晶片是次世代定序(NGS) 技術的進步,使大規模並行定定序對於任何實驗室來說都具有成本效益。因此,增強NGS應用的生物晶片的開發預計將支持該行業的成長。同樣,增加政府推動國內生物晶片生產的舉措可能會支持未來幾年的成長。這項策略性舉措旨在滿足當地產品的需求和供應。例如,2022 年 7 月,SiPhox, Inc. 從 Baker-Polito 政府獲得了價值 681,631 美元的津貼。

這筆資金將加速大規模生產可插拔光子生物晶片的製造設施的開發。為了滿足藥物發現、疫苗開發和分散式診斷等生物技術領域日益成長的需求,預計生物晶片的產量將從每月約100片加速至每月約5000片。此類投資可能會在未來幾年補充產業成長。預計 COVID-19 大流行將對預測期內的行業成長產生積極影響。多家公司齊心協力開發創新解決方案來應對這場流行病。例如,2020 年 3 月,SkyWater Technology 宣布與華大智造合作,為 COVID-19 定序提供必要的組件,包括微射流微機電設備。

對個人化醫療日益成長的需求很可能成為未來幾年該行業的重要應用領域。隨著生物晶片逐漸成為分子診斷的重要組成部分,它們在照護現場診斷中的使用有望促進個人化醫療的發展。此外,使用微陣列進行基因表現分析有望推進基於分子分類的個人化癌症治療。然而,生產生物晶片的成本相當高,導致最終用戶的價格較高。例如,Josep Carreras 白血病研究所 (IJC) 為研究人員提供微陣列。 GeneChip Human Gene 2.0 ST 全轉錄本表達分析和新鮮樣本的分析成本在 456 美元到 593 美元之間。

生物晶片市場報告亮點

  • 由於對快速準確檢測癌症的需求很高,DNA 晶片類型在 2024 年佔據最大的收益佔有率。
  • 由於生物晶片有助於降低藥物發現和開發的總體成本,實驗室晶片藥物發現應用領域預計在預測期內將以更快的速度成長。
  • 由於藥物發現和開發的增加以及對個人化藥物的需求,生物技術和製藥最終用戶細分市場在 2024 年獲得了可觀的收益佔有率。
  • 由於對新興企業和生物晶片應用開發的高研發投資和創業投資,北美在 2024 年佔據了最大的收益佔有率。
  • 預計 2025 年至 2030 年,亞太地區的複合年成長率將是最快的。這是由於地方政府為促進國內產品製造而採取的各種措施。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章集團業務類型分析

  • 類型細分儀表板
  • 生物晶片市場類型波動分析
  • 2018-2030年生物晶片市場規模與趨勢分析(按類型)
  • DNA晶片
    • 2018-2030 年 DNA 晶片市場估計與預測
    • 癌症診斷和治療
    • 基因表現
    • SNP基因型鑒定
    • 基因組學
    • 藥物發現
    • 農業生物技術
    • 其他
  • 蛋白質晶片
    • 2018-2030 年蛋白質晶片市場估計與預測
    • 蛋白質體學
    • 表達譜
    • 診斷
    • HTS
    • 藥物發現
    • 其他
  • 實驗室晶片
    • 2018-2030 年實驗室晶片市場估計與預測
    • 基因組學
    • 體外診斷和POC
    • 蛋白質體學
    • 藥物發現
    • 其他
  • 組織陣列
    • 2018-2030 年組織陣列市場估計與預測
  • 單元陣列
    • 2018-2030 年單元陣列市場估計與預測

第5章 依最終用途分類的業務分析

  • 最終用途細分儀表板
  • 生物晶片市場最終用途波動分析
  • 2018-2030 年生物晶片市場規模與趨勢分析(依最終用途)
  • 生物技術和製藥公司
  • 醫院和診斷中心
  • 學術研究所
  • 其他

第6章 區域業務分析(按類型、最終用途)

  • 區域儀表板
  • 2024年及2030年市場規模及預測與趨勢分析
  • 北美洲
    • 北美生物晶片市場,2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲生物晶片市場,2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太生物晶片市場,2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲生物晶片市場,2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲生物晶片市場,2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 公司分類
  • 策略規劃
  • 2024 年企業市場分析
  • 公司簡介
    • Agilent Technologies
    • PerkinElmer, Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools Inc.
    • GE HealthCare
    • IBIOCHIPS
    • LI-COR, Inc.
    • Cellix Ltd
    • Randox Laboratories Ltd.
Product Code: GVR-1-68038-077-4

Biochip Market Growth & Trends:

The global biochip market size is estimated to reach USD 26.30 billion by 2030, expanding at a CAGR of 11.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.

Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.

The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.

The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.

Biochip Market Report Highlights:

  • The DNA chips type segment accounted for the largest revenue share in 2024 due to the high demand for rapid and accurate detection of cancer
  • The drug discovery application segment for lab-on-chip is anticipated to grow at a faster rate during the forecast period as the biochip helps lower the overall cost of drug discovery & development
  • The biotechnology and pharmaceutical companies end-user segment captured a significant revenue share in 2024 due to the need for personalized medicines along with the increasing drug discovery & development
  • North America held the largest revenue share in 2024 owing to high R&D investment coupled with the accessibility of capital through venture capitalists for startups and the application development of biochips in the region
  • Asia Pacific is projected to register the fastest CAGR from 2025 to 2030 owing to various initiatives by local governments to promote domestic product manufacturing

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Type Segment
    • 1.1.2. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Primary Research
  • 1.6. Information or Data Analysis:
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in adoption of next-generation sequencing
      • 3.2.1.2. Growing R&D in proteomics and genomics
      • 3.2.1.3. Presence of an extensive drug-development pipeline
      • 3.2.1.4. Increasing adoption of personalized medicine
      • 3.2.1.5. Rapid technological advances in biochip technology
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of manufacturing
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Group Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Biochip Market Type Movement Analysis
  • 4.3. Biochip Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. DNA Chips
    • 4.4.1. DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Cancer Diagnosis and Treatment
      • 4.4.2.1. Cancer diagnosis and treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Gene Expression
      • 4.4.3.1. Gene expression market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. SNP Genotyping
      • 4.4.4.1. SNP genotyping market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Genomics
      • 4.4.5.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Drug Discovery
      • 4.4.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Agricultural Biotechnology
      • 4.4.7.1. Agricultural biotechnology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.8. Others
      • 4.4.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Protein Chips
    • 4.5.1. Protein chips market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Proteomics
      • 4.5.2.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Expression Profiling
      • 4.5.3.1. Expression profiling market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Diagnostics
      • 4.5.4.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. HTS
      • 4.5.5.1. HTS market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Drug Discovery
      • 4.5.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Lab-on-chip
    • 4.6.1. Lab-on-chip market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Genomics
      • 4.6.2.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. IVD & POC
      • 4.6.3.1. IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Proteomics
      • 4.6.4.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Drug Discovery
      • 4.6.5.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Tissue Arrays
    • 4.7.1. Tissue arrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Cell Arrays
    • 4.8.1. Cell arrays market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Biochip Market End Use Movement Analysis
  • 5.3. Biochip Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Biotechnology & Pharmaceutical Companies
    • 5.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Hospitals & Diagnostic Centers
    • 5.5.1. Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Academic & Research Institute
    • 5.6.1. Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis by Type, End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. North America Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Target Disease Prevalence
      • 6.3.2.4. U.S. Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Target Disease Prevalence
      • 6.3.3.4. Canada Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Target Disease Prevalence
      • 6.3.4.4. Mexico Biochip Market, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Target Disease Prevalence
      • 6.4.2.4. UK Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Target Disease Prevalence
      • 6.4.3.4. Germany Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Target Disease Prevalence
      • 6.4.4.4. France Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Target Disease Prevalence
      • 6.4.5.4. Italy Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Target Disease Prevalence
      • 6.4.6.4. Spain Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Denmark Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Target Disease Prevalence
      • 6.4.8.4. Sweden Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Target Disease Prevalence
      • 6.4.9.4. Norway Biochip Market, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Japan Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. China Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Target Disease Prevalence
      • 6.5.4.4. India Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Target Disease Prevalence
      • 6.5.5.4. Australia Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Target Disease Prevalence
      • 6.5.6.4. Thailand Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Target Disease Prevalence
      • 6.5.7.4. South Korea Biochip Market, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Target Disease Prevalence
      • 6.6.2.4. Brazil Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Target Disease Prevalence
      • 6.6.3.4. Argentina Biochip Market, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Target Disease Prevalence
      • 6.7.2.4. South Africa Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Target Disease Prevalence
      • 6.7.3.4. Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Target Disease Prevalence
      • 6.7.4.4. UAE Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Target Disease Prevalence
      • 6.7.5.4. Kuwait Biochip Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Agilent Technologies
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. PerkinElmer, Inc.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Illumina, Inc.
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Bio-Rad Laboratories, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Standard BioTools Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. GE HealthCare
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. IBIOCHIPS
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. LI-COR, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cellix Ltd
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Randox Laboratories Ltd.
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global biochip market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global biochip market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America biochip market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America biochip market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. biochip market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada biochip market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico biochip market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Europe biochip market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe biochip market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany biochip market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK biochip market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 21 France biochip market, by type, 2018 - 2030 (USD Million)
  • Table 22 France biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Italy biochip market, by type, 2018 - 2030 (USD Million)
  • Table 24 Italy biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Spain biochip market, by type, 2018 - 2030 (USD Million)
  • Table 26 Spain biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Denmark biochip market, by type, 2018 - 2030 (USD Million)
  • Table 28 Denmark biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Sweden biochip market, by type, 2018 - 2030 (USD Million)
  • Table 30 Sweden biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Norway biochip market, by type, 2018 - 2030 (USD Million)
  • Table 32 Norway biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific biochip market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific biochip market, by type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 36 China biochip market, by type, 2018 - 2030 (USD Million)
  • Table 37 China biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Japan biochip market, by type, 2018 - 2030 (USD Million)
  • Table 39 Japan biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 40 India biochip market, by type, 2018 - 2030 (USD Million)
  • Table 41 India biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea biochip market, by type, 2018 - 2030 (USD Million)
  • Table 43 South Korea biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Australia biochip market, by type, 2018 - 2030 (USD Million)
  • Table 45 Australia biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Thailand biochip market, by type, 2018 - 2030 (USD Million)
  • Table 47 Thailand biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Latin America biochip market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America biochip market, by type, 2018 - 2030 (USD Million)
  • Table 50 Latin America biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Brazil biochip market, by type, 2018 - 2030 (USD Million)
  • Table 52 Brazil biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Argentina biochip market, by type, 2018 - 2030 (USD Million)
  • Table 54 Argentina biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa biochip market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa biochip market, by type, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 58 South Africa biochip market, by type, 2018 - 2030 (USD Million)
  • Table 59 South Africa biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia biochip market, by type, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 62 UAE biochip market, by type, 2018 - 2030 (USD Million)
  • Table 63 UAE biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait biochip market, by type, 2018 - 2030 (USD Million)
  • Table 65 Kuwait biochip market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Biochip market: market outlook
  • Fig. 7 Biochip competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Biochip market driver impact
  • Fig. 10 Biochip market restraint impact
  • Fig. 11 Biochip market: Type movement analysis
  • Fig. 12 Biochip market: Type outlook and key takeaways
  • Fig. 13 DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Cancer diagnostics & treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Gene expression market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 16 SNP genotyping market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 17 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Agricultural biotechnology market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Protein chips market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Proteomics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Expression profiling market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 HTS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Drug discovery market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 28 Lab-on-chip market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 29 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Proteomics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 32 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Biochip market: End use movement analysis
  • Fig. 35 Biochip market: End use outlook and key takeaways
  • Fig. 36 Biotechnology & pharmaceutical companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 North America biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Italy biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Norway biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 China biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Japan biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 UAE biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Market share of key market players - Biochip market